Cite
HARVARD Citation
, . et al. (2022). Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. European heart journal. pp. 1416-1424. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
, . et al. (2022). Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. European heart journal. pp. 1416-1424. [Online].